ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2020/06/23 | 1,730 | 1,733 | 1,671 | 1,693 | -33 | -1.9% | 718,000 |
| 2020/06/22 | 1,728 | 1,745 | 1,702 | 1,726 | +9 | +0.5% | 475,200 |
| 2020/06/19 | 1,727 | 1,727 | 1,683 | 1,717 | +5 | +0.3% | 453,400 |
| 2020/06/18 | 1,708 | 1,733 | 1,689 | 1,712 | +14 | +0.8% | 419,700 |
| 2020/06/17 | 1,700 | 1,723 | 1,675 | 1,698 | +9 | +0.5% | 577,300 |
| 2020/06/16 | 1,640 | 1,695 | 1,633 | 1,689 | +105 | +6.6% | 662,000 |
| 2020/06/15 | 1,650 | 1,693 | 1,575 | 1,584 | -49 | -3% | 886,800 |
| 2020/06/12 | 1,611 | 1,672 | 1,589 | 1,633 | -87 | -5.1% | 1,198,700 |
| 2020/06/11 | 1,801 | 1,814 | 1,718 | 1,720 | -88 | -4.9% | 1,054,900 |
| 2020/06/10 | 1,774 | 1,810 | 1,766 | 1,808 | +17 | +0.9% | 808,300 |
| 2020/06/09 | 1,790 | 1,808 | 1,756 | 1,791 | -9 | -0.5% | 761,800 |
| 2020/06/08 | 1,837 | 1,860 | 1,734 | 1,800 | -53 | -2.9% | 2,336,300 |
| 2020/06/05 | 1,732 | 1,971 | 1,719 | 1,853 | +116 | +6.7% | 4,040,500 |
| 2020/06/04 | 1,790 | 1,804 | 1,716 | 1,737 | -46 | -2.6% | 909,300 |
| 2020/06/03 | 1,798 | 1,798 | 1,764 | 1,783 | -8 | -0.4% | 672,200 |
| 2020/06/02 | 1,800 | 1,810 | 1,771 | 1,791 | +6 | +0.3% | 543,200 |
| 2020/06/01 | 1,793 | 1,794 | 1,761 | 1,785 | -33 | -1.8% | 789,000 |
| 2020/05/29 | 1,803 | 1,860 | 1,797 | 1,818 | +54 | +3.1% | 1,577,900 |
| 2020/05/28 | 1,795 | 1,811 | 1,726 | 1,764 | -28 | -1.6% | 890,000 |
| 2020/05/27 | 1,777 | 1,804 | 1,750 | 1,792 | -3 | -0.2% | 713,800 |
| 2020/05/26 | 1,812 | 1,826 | 1,782 | 1,795 | -7 | -0.4% | 725,000 |
| 2020/05/25 | 1,791 | 1,841 | 1,791 | 1,802 | +8 | +0.4% | 824,700 |
| 2020/05/22 | 1,814 | 1,829 | 1,781 | 1,794 | -31 | -1.7% | 747,700 |
| 2020/05/21 | 1,830 | 1,857 | 1,809 | 1,825 | -31 | -1.7% | 1,044,200 |
| 2020/05/20 | 1,800 | 1,866 | 1,788 | 1,856 | +56 | +3.1% | 1,088,500 |
| 2020/05/19 | 1,820 | 1,828 | 1,756 | 1,800 | +11 | +0.6% | 1,313,300 |
| 2020/05/18 | 1,732 | 1,832 | 1,722 | 1,789 | +102 | +6% | 1,996,300 |
| 2020/05/15 | 1,630 | 1,714 | 1,611 | 1,687 | +94 | +5.9% | 1,369,300 |
| 2020/05/14 | 1,550 | 1,663 | 1,521 | 1,593 | +24 | +1.5% | 2,363,400 |
| 2020/05/13 | 1,550 | 1,586 | 1,544 | 1,569 | +7 | +0.4% | 777,300 |
| 2020/05/12 | 1,540 | 1,572 | 1,530 | 1,562 | +32 | +2.1% | 758,000 |
| 2020/05/11 | 1,518 | 1,549 | 1,500 | 1,530 | +12 | +0.8% | 871,900 |
| 2020/05/08 | 1,568 | 1,570 | 1,500 | 1,518 | -22 | -1.4% | 1,137,300 |
| 2020/05/07 | 1,541 | 1,554 | 1,501 | 1,540 | -37 | -2.3% | 1,614,600 |
| 2020/05/01 | 1,529 | 1,586 | 1,473 | 1,577 | +67 | +4.4% | 2,476,700 |
| 2020/04/30 | 1,565 | 1,573 | 1,505 | 1,510 | -27 | -1.8% | 1,224,600 |
| 2020/04/28 | 1,525 | 1,545 | 1,496 | 1,537 | +51 | +3.4% | 989,400 |
| 2020/04/27 | 1,442 | 1,509 | 1,437 | 1,486 | +69 | +4.9% | 991,100 |
| 2020/04/24 | 1,424 | 1,435 | 1,388 | 1,417 | -4 | -0.3% | 478,100 |
| 2020/04/23 | 1,401 | 1,452 | 1,400 | 1,421 | +47 | +3.4% | 855,100 |
| 2020/04/22 | 1,380 | 1,411 | 1,345 | 1,374 | -16 | -1.2% | 713,700 |
| 2020/04/21 | 1,460 | 1,491 | 1,390 | 1,390 | -78 | -5.3% | 1,124,300 |
| 2020/04/20 | 1,417 | 1,469 | 1,417 | 1,468 | +49 | +3.5% | 761,800 |
| 2020/04/17 | 1,465 | 1,469 | 1,407 | 1,419 | -16 | -1.1% | 781,500 |
| 2020/04/16 | 1,418 | 1,477 | 1,417 | 1,435 | +9 | +0.6% | 934,300 |
| 2020/04/15 | 1,429 | 1,457 | 1,396 | 1,426 | -33 | -2.3% | 1,187,700 |
| 2020/04/14 | 1,370 | 1,496 | 1,353 | 1,459 | +115 | +8.6% | 2,337,600 |
| 2020/04/13 | 1,333 | 1,359 | 1,325 | 1,344 | +17 | +1.3% | 573,000 |
| 2020/04/10 | 1,349 | 1,356 | 1,294 | 1,327 | -10 | -0.7% | 627,700 |
| 2020/04/09 | 1,367 | 1,380 | 1,313 | 1,337 | -14 | -1% | 1,130,000 |
1051～
1100
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.30倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
